Heron Financial Group’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q2 | $497K | Buy |
1,745
+35
| +2% | +$9.97K | 0.27% | 84 |
|
2023
Q1 | $475K | Buy |
1,710
+11
| +0.6% | +$3.06K | 0.26% | 81 |
|
2022
Q4 | $461K | Hold |
1,699
| – | – | 0.31% | 72 |
|
2022
Q3 | $454K | Sell |
1,699
-210
| -11% | -$56.1K | 0.28% | 78 |
|
2022
Q2 | $389K | Buy |
1,909
+230
| +14% | +$46.9K | 0.24% | 88 |
|
2022
Q1 | $354K | Sell |
1,679
-90
| -5% | -$19K | 0.18% | 102 |
|
2021
Q4 | $406K | Sell |
1,769
-48
| -3% | -$11K | 0.22% | 92 |
|
2021
Q3 | $514K | Hold |
1,817
| – | – | 0.29% | 74 |
|
2021
Q2 | $629K | Hold |
1,817
| – | – | 0.36% | 64 |
|
2021
Q1 | $506K | Hold |
1,817
| – | – | 0.31% | 74 |
|
2020
Q4 | $455K | Buy |
1,817
+10
| +0.6% | +$2.5K | 0.31% | 73 |
|
2020
Q3 | $514K | Sell |
1,807
-45
| -2% | -$12.8K | 0.41% | 64 |
|
2020
Q2 | $516K | Buy |
1,852
+18
| +1% | +$5.02K | 0.46% | 53 |
|
2020
Q1 | $612K | Sell |
1,834
-54
| -3% | -$18K | 0.63% | 43 |
|
2019
Q4 | $627K | Buy |
+1,888
| New | +$627K | 0.52% | 50 |
|